Background {#Sec1}
==========

Mechanical ventilation is a life-saving intervention \[[@CR1]\]. In the intensive care unit (ICU), the timing of liberation from invasive mechanical ventilation is an important issue for clinicians caring for critically ill intubated patients receiving mechanical ventilation, and differs from the extubation procedure after elective surgery \[[@CR1]\]. The benefit-risk ratio for extubation has to be assessed on a daily basis. If the patient remains intubated too long, complications associated with prolonged mechanical ventilation may appear \[[@CR2]\]. On the other hand, if the patient is extubated too early, reintubation is associated with higher mortality and long-term disability \[[@CR3]--[@CR5]\]. Extubation failure is defined as the need for reintubation within 24--72 h \[[@CR4]--[@CR8]\] or up to 7 days \[[@CR9]\].

Causes of extubation failure include upper airway obstruction (stridor mainly related to laryngeal edema), lower airway obstruction (aspiration or excessive respiratory secretions), congestive heart failure, respiratory failure, or encephalopathy (decreased consciousness leading to hypoventilation) \[[@CR10]\]. After resolution of illness, mechanically ventilated patients are liberated from the ventilator, a process termed "weaning" \[[@CR8]\]. Weaning and extubation, though following each other in clinical practice, are two separate processes that pose distinct problems. Extubation failure can be due to "airway failure" and/or "non-airway failure" which also refers to "weaning failure" \[[@CR5], [@CR10]\]. Airway failure, defined as the inability to breathe without an endotracheal tube, differs from weaning failure also assimilated to non-airway failure, defined as the inability to breathe without invasive mechanical ventilation \[[@CR3]\].

It will be of interest to distinguish between airway failure and non-airway failure/weaning failure because the two conditions will be managed differently, both for prevention and curative strategies.

Several methods for anticipating/managing non-airway failure have been explored, including spontaneous breathing trials (SBT) \[[@CR11], [@CR12]\], careful cardiac assessment using brain natriuretic peptide \[[@CR13]\] or cardiac ultrasound during SBT \[[@CR14], [@CR15]\]. Ultrasound is used to evaluate the heart, diaphragm, pleura and lungs during the weaning process \[[@CR16]--[@CR19]\]. Regarding prevention of airway failure, the cuff-leak test is one of the tools developed for identifying a cause related to upper-airway failure associated with laryngeal edema: post-extubation stridor \[[@CR20], [@CR21]\]. Cough expiratory peak-flow and evaluation of the amount of secretions have been proposed as tools to identify patients at risk of developing lower-airway failure \[[@CR22]\].

To date, only one single-center retrospective study published in 1998 \[[@CR10]\] including 74 medical ICU patients who required reintubation has reported the respective incidences of airway failure (31%) and non-airway failure (69%). To our knowledge, no study has specifically evaluated the risk factors related to airway failure as opposed to non-airway failure, respectively.

We hypothesized that the two mechanisms that lead to extubation failure, namely airway failure and non-airway failure, are also associated with specific determinants of occurrence. We then performed a large multicenter prospective study to identify risk factors for each component of extubation failure.

This work was presented as an abstract at the meeting of the Société de Réanimation de Langue Française (Paris 2017).

Methods {#Sec2}
=======

Conduct of the study, patient population and inclusion/exclusion criteria {#Sec3}
-------------------------------------------------------------------------

A prospective, observational, multicenter study was conducted in 26 ICUs. All consecutive adult patients extubated in participating ICUs were included. Exclusion criteria included age \< 18 years, pregnancy, and terminal extubation \[[@CR23]\]. Patients who died before extubation and/or with tracheotomy were not eligible. In patients undergoing more than one extubation episode, each extubation procedure was considered. Additional detail on the method for collecting data is provided in Additional file [1](#MOESM1){ref-type="media"}.

Ethics approval {#Sec4}
---------------

The appropriate Institutional Review Board (*Comité de Protection des personnes Sud-Mediterranée III*) approved the study protocol (code UF: 9242, register: 2013-A01402--43) and, based on the observational design, waived the need for written informed consent. Next of kin were informed of the study, as were patients, as soon as their neurologic status was deemed adequate. Written information was delivered to the patient's next of kin and to the patient when neurologic recovery was deemed appropriate. The study was registered on ClinicalTtrials.gov (identifier number NCT 02450669).

Definition of extubation failure, airway failure and non-airway failure {#Sec5}
-----------------------------------------------------------------------

Extubation failure was defined as a need for reintubation within 48 h after extubation \[[@CR8]\]. Patients were categorized into airway failure or non-airway failure according to the principal cause determined by the medical ICU team members. To limit the misclassification of each cause of extubation failure, the participating centers were asked to have two persons classify each reintubated patient, to assess the mechanisms of extubation failure. In case of disagreement and/or difficulty in classification, two independent observers (SJ and ADJ) made the final classification.

Extubation failure due to airway failure was defined as an extubation failure because of the inability to breathe without a tracheal tube, according to previously published definitions by Epstein et al. \[[@CR10]\]. Following the Epstein et al. \[[@CR10]\] definition, included in this category were upper-airway obstruction and lower-airway obstruction due to aspiration or excessive respiratory secretions (witnessed aspiration or inability to maintain airway patency because of respiratory secretions, defined as the need for repeated naso-tracheal aspiration or the development of atelectasis during the post-extubation period, because of ineffective cough or inability to expectorate) \[[@CR10]\].

Extubation failure due to non-airway failure was defined as an extubation failure related to the inability to breathe without invasive mechanical ventilation, according to previously published definitions by Epstein et al. \[[@CR10]\]. Following the Epstein et al. \[[@CR10]\] definition, congestive heart failure, respiratory failure (lung disease) and hypoventilation were included in this category \[[@CR10]\].

Extubation failure due to mixed airway and non-airway failures was defined when a main mechanism (i.e. airway failure or non-airway failure) of reintubation could not be defined (cases of "uncertainty"), because both airway failure and non-airway failure could explain the extubation failure. Figure S1 in Additional file [1](#MOESM1){ref-type="media"} summarizes the definitions of airway failure, non-airway failure and mixed airway and non-airway failures.

Data handling {#Sec6}
-------------

The primary outcome was airway failure. The secondary outcomes were non-airway failure, mixed airway and non-airway failures, the rate of difficult intubation in the case of extubation failure, late reintubation (between 2 days and 7 days), the reintubation delays, the use and the length of mechanical or non-invasive ventilation, the need for vasopressors or dialysis after extubation, the occurrence of hospital-acquired infections (nosocomial pneumonia, catheter infections, bacteremia, urinary infections) and mortality at day 28.

Statistics {#Sec7}
----------

The number of subjects to be included in the study was calculated to obtain composite criteria for airway failure. Considering sensitivity of 90% ± 7% based upon a 7% incidence of airway failure \[[@CR3], [@CR10], [@CR20]\], it was estimated that 1015 extubation procedures would be required. Taking missing data into account, we decided to include 1500 extubation procedures to develop the model. This sample size also enabled us to obtain composite criteria for non-airway failure (with an estimated incidence at 5%) \[[@CR3], [@CR10], [@CR20]\].

Quantitative variables were expressed as means (standard deviation) or medians (interquartiles 25--75%) and compared using the Student *t* test or the Wilcoxon test as appropriate (Gaussian or non-Gaussian variables). Qualitative variables were compared using the chi-squared test or the Fisher test as appropriate.

Patients with mixed airway failures and non-airway failures were excluded from the first analysis. As the dependent variable (extubation failure) consists of three non-ordinal categories, airway failure, non-airway failure and extubation success and were analyzed by multinomial logistic regression \[[@CR24]\]. The multinomial logistic regression allows simultaneous comparison of "airway failure" and "non-airway failure" with "extubation success". A multivariate multinomial logistic model was established. Interactions between variables were tested. All variables with *P* values \< 0.20 in the univariate multinomial logistic regression analysis were entered into the model and a backward procedure was used to select the final model, keeping only significant variables with *P* values \< 0.05. Odds ratios (ORs) with 95% confidence intervals (CIs) for response were calculated using "Extubation success" as the reference category. The effect of center was assessed by entering this variable in a random effects model as a fixed and random effect \[[@CR25]\].

In a second analysis (sensitivity analysis), patients with mixed airway and non-airway failures were included in both the airway failure and non-airway failure groups. In a third analysis (sensitivity analysis), only the first extubation procedure for each patient was included. In a fourth analysis (sensitivity analysis), excessive respiratory secretions were included in the non-airway failure group instead of the airway failure group. In the case of missing values (considered as missing completely at random (MCAR)), no method of replacement was used. A complete case analysis was done (listwise deletion).

A *P* value ≤ 0.05 was considered statistically significant. The statistical analysis was performed by the medical statistical department of the Montpellier University Hospital with the help of statistical software (SAS, version 9.3; SAS Institute; Cary, NC, USA and R, version 2.14.1).

Results {#Sec8}
=======

From December 2013 to May 2015, 1514 extubation procedures were studied in 1453 patients from 26 centers. All the extubation procedures were included: 61 patients (4.0%) were intubated twice. The median (interquartile range, IQR) number of procedures enrolled in each center was 27 (11--72). The flow chart for the study is shown in Fig. [1](#Fig1){ref-type="fig"}. The incidence of extubation failure was 10.4% (157 of 1514 intubation-procedures), with airway failure, non-airway failure and mixed airway and non-airway failures incidences of 4.6% (70 of 1514), 5.2% (78 of 1514) and 0.6% (9 of 1514), respectively. Among the 157 extubation procedures, 26 (17%) were misclassified or not classified and needed final classification by the two independent observers.Fig. 1Flow chart for the study. From December 2013 to May 2015, 1514 extubation procedures were studied in 1453 patients from 26 centers. All extubation procedures were included: 61 patients (4.0%) were intubated twice. The median (interquartile range, IQR) number of intubation procedures included per center was 27 (11--72). The incidence of extubation failure (H48 means during the 48 hours following extubation) was 10.4% (157 of 1514 intubation procedures), with "airway"-failure, non-airway failure and mixed airway and non-airway failure incidences, respectively, of 4.6% (70 of 1514), 5.2% (78 of 1514) and 0.6% (9 of 1514)

Table [1](#Tab1){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}: Table S1 summarize~~s~~ information on patient and intubation characteristics, the parameters before extubation and the SBTs performed, and Table S2 (Additional file [1](#MOESM1){ref-type="media"}) provides information on the usual functional parameters predicting extubation failure, according to airway failure and non-airway failure, compared to extubation success. The main parameters evaluated during and after the extubation procedure are presented in Table [2](#Tab2){ref-type="table"}.Table 1Patient and intubation characteristics, parameters before extubation and spontaneous breathing trial according to airway failure, non-airway failure and extubation success with corresponding crude odds ratios determined using multinomial logistic regressionCharacteristicExtubation success (*n* = 1357)Airway failure (*n* = 70)Non-airway failure (*n* = 78)OR95% CI*P* valueOR95% CI*P* valueAge, years61 (49--71)61 (51--71)1.0020.987--1.0170.7965 (51--72)1.0090.994--1.0230.24Female sex490/1352 (36)36/69 (52)1.9191.181--3.1180.00930 (38)1.0990.688--1.7580.69SAPS249 (36--62)48 (40--56)1.0100.996--1.0240.1848 (37--62)1.0191.006--1.0320.004SOFA score before extubation2 (0--4)2 (1--3)0.9540.876--1.0390.283 (1--5)1.0541.009--1.1010.02SOFA score ≥ 8 before extubation107 (8)3 (4)0.5230.162--1.6910.2815 (19)2.7811.532--5.0510.0008Weight, kg75 (63--85)70 (59--87)0.9900.976--1.0040.1870 (61--80)0.9820.968--0.9960.01Height, cm170 (163--175)166 (160--174)0.9620.937--0.9880.004168 (160--175)0.9820.958--1.0070.16Body mass index (kg/m^2^)25.5 (22.5--29.4)26.6 (21.5--28.5)1.0000.962--1.0391.0024.2 (21.1--27.8)0.9580.916--1.0020.06Body mass index \< 30 kg/m^2^278 (20)53 (76)1.1310.608--2.1050.7064 (82)1.7760.900--3.5020.10Medical type of admission589 (43)39 (56)1.6000.986--2.5950.0639 (50)1.2720.805--2.0080.30Smoking349 (26)13 (19)0.6590.356--1.2180.1816 (21)0.7450.425--1.3090.31COPD173 (13)10 (14)1.1410.573--2.2700.719 (12)0.8930.438--1.8210.75Alcoholism295 (22)14 (20)0.9000.494--1.6390.7319 (24)1.1590.680--1.9750.59Cirrhosis159 (12)7 (10)0.8370.377--1.8600.668 (10)0.8610.407--1.8230.70Chronic renal failure168 (12)5 (7)0.5440.216--1.3710.207 (9)0.6980.316--1.5420.37Reason for ICU admission Acute respiratory failure286 (21)21 (30)1.6050.947--2.7200.0821 (27)1.3800.823--2.3140.22 Trauma103 (8)9 (13)1.7960.867--3.7200.112 (3)0.3200.078--1.3230.12 Post-operative488 (36)11 (16)0.3320.173--0.6380.000920 (26)0.6140.365--1.0330.07 Cardiac arrest42 (3)1 (1)0.4540.062--3.3460.447 (9)3.0871.339--7.1150.008 Neurologic failure356 (26)38 (54)2.6261.604--4.2990.00128 (36)1.3680.815--2.2930.24 Shock242 (18)13 (19)1.0510.566--1.9500.8814 (18)1.0080.556--1.8270.98 Ascetic decompensation24 (2)1 (1)0.8050.107--6.0370.830 (0)----0.98 Acute renal failure31 (2)2 (3)1.2580.295--5.3670.762 (3)1.1260.264--4.7910.87 Others115 (8)3 (4)0.4840.150--1.5620.227 (9)1.0650.479--2.3690.88Reason for intubation Acute respiratory failure298 (22)26 (37)2.1001.272--3.4680.00424 (31)1.5790.960--2.5980.07 Shock146 (11)10 (14)1.3820.693--2.7590.366 (8)0.6910.295--1.6180.39 Coma308 (23)29 (41)2.4091.473--3.9410.000524 (31)1.5140.921--2.4890.10 Cardiac arrest43 (3)1 (1)0.4430.060--3.2640.428 (10)3.4921.582--7.7110.002 Surgery451 (33)9 (13)0.2970.146--0.6030.000816 (21)0.5180.296--0.9090.02 Others135 (10)3 (4)0.4840.150--1.5620.228 (10)1.0650.479--2.3690.88Length of intubation (days)2.0 (1.0--6.0)4.5 (1.0--9.0)1.0290.997--1.0610.073.5 (1.0--7.0)1.0381.011--1.0670.007Length of intubation \> 8 days203 (15)20 (29)2.1741.267--3.7290.00514 (18)1.2680.695--2.3120.439Strong cough strength546 (40)20 (29)0.5940.350--1.0090.0512 (15)0.2700.145--0.504\< 0.0001Copious endotracheal secretions147 (11)23 (33)4.0282.377--6.825\< 0.00016 (8)0.6860.293--1.6050.38Data are summarized as number of extubation procedures/total number of extubation procedures (%) or median (interquartile range). One patient can have more than one reason for ICU admission or for intubation. All *P* values and ORs result from univariate multinomial logistic regression predicting the two modalities of extubation failure (airway failure versus non-airway failure) according to the characteristics*OR* odds ratio, *CI* confidence interval, *SAPS2* simplified acute physiologic score, *SOFA* sequential organ failure assessment, *COPD* chronic obstructive respiratory diseaseTable 2Parameters during and after extubation according to airway failure, non-airway failure and extubation success with corresponding crude odds ratios determined using multinomial logistic regressionCharacteristicExtubation success (*n* = 1357)Airway failure (*n* = 70)Non-airway-failure (*n* = 78)OR95% CI*P* valueOR95% CI*P* valueOperator performing extubation Senior368/1269 (29)24/63 (38)----23/69 (33)---- Junior451/1269 (36)13/63 (21)0.4990.253--0.9830.0421/69 (30)0.8380.462--1.5190.68 Nurse450/1269 (35)26/63 (41)1.1290.637--1.9990.5625/69 (36)1.1250.628--2.0150.69Extubation at the end of inspiration121/1143 (11)8/58 (14)1.1200.471--2.6650.807/66 (11)1.1900.469--3.0220.71Extubation at the end of expiration108/1143 (9)4/58 (7)0.6250.206--1.9000.417/66 (11)1.4310.556--3.6820.46Extubation without preference914/1143 (80)46/58 (79)3.4220.465--25.1970.2352/66 (79)3.8690.527--28.4140.18Suctioning before extubation1123 (83)52 (74)0.7870.380--1.6290.5263 (81)1.0730.504--2.2820.86FiO2 set at 100% before extubation417 (31)21 (30)1.2940.732--2.2890.3825 (32)1.1010.661--1.8310.71Recruitment maneuvers before extubation127 (9)5 (7)0.9590.373--2.4640.935 (6)0.6650.262--1.6840.39Accidental extubation6 (0)1 (1)6.5410.672--63.6990.110 (0)----0.98Self-extubation69 (5)5 (7)1.4360.560--3.6810.457 (9)1.8400.816--4.1510.14Extubation protocol441 (32)14 (20)0.5190.286--0.9430.0324 (31)0.9230.563--1.5130.75Patient informed of extubation1225 (90)64 (91)1.1490.488--2.7050.7567 (86)0.6560.338--1.2730.21Daytime extubation896 (66)55 (79)2.1411.275--3.5930.00458 (74)1.3050.746--2.2820.35Physiotherapy672 (50)46 (66)1.9541.179--3.2370.00946 (59)1.4650.922--2.3290.11 Before extubation283/672 (42)23/46 (50)0.7920.341--1.8400.5917/46 (37)1.1710.383--3.5820.78 Between extubation and 1 h after470/672 (70)31/46 (67)0.9230.314--2.7120.8833/46 (72)1.9660.459--8.4130.36 More than 1 h after236/672 (35)12/46 (26)0.4160.177--0.9770.0422/46 (48)2.7960.817--9.5680.10Preventive NIV post extubation290 (21)22 (31)1.7570.697--4.4320.2328 (36)2.2370.905--5.5270.08Curative NIV post extubation238 (18)11 (16)0.8770.454--1.6940.7016 (21)1.2130.688--2.1390.50Inhaled corticosteroids post extubation68 (5)13 (19)4.3732.279--8.392\< 0.00016 (8)1.5860.665--3.7800.30Inhaled epinephrine post extubation40 (3)17 (24)10.5195.593--19.781\< 0.00013 (4)1.3410.405--4.4380.63Data are summarized as number of extubation procedures/total number of extubation procedures (%) or median (interquartile range). All *P* values and ORs result from a univariate multinomial logistic regression predicting the two modalities of extubation failure (airway failure versus non-airway failure) according to the characteristics*OR* odds ratio, *CI* confidence interval, *FiO2* fraction of inspired oxygen, *NIV* non-invasive ventilation

In the final, multivariate model, the main predictors of airway failure were related to patient characteristics and conditions prior to extubation: female gender (OR 2.024 (1.187--3.450), *P* = 0.010), baseline pathology with coma as a reason for intubation (OR 4.979 (2.797--8.864), *P* \< 0.0001), acute respiratory failure as a reason for intubation (OR 3.395 (1.877--6.138), *P* \< 0.0001), length of ventilation \> 8 days (OR 1.956 (1.087--3.518), *P* = 0.025), copious secretions at the time of extubation (OR 4.066 (2.268--7.292), *P* \< 0.0001) and absence of strong cough before extubation (OR 1.876 (1.047--3.362), *P* = 0.035) (Fig. [2](#Fig2){ref-type="fig"}). The main predictors of non-airway failure were also related to patient characteristics and conditions prior to extubation: non obese status (OR 2.153 (1.052--4.408), *P* = 0.036), baseline pathology with coma as a reason for intubation (OR 2.177 (1.301--3.642), *P* = 0.003), acute respiratory failure as a reason for intubation (OR 2.067 (1.217--3.510), *P* = 0.0072), absence of strong cough before extubation (OR 3.240 (1.786--5.879), *P* = 0.0001) and sequential organ failure assessment (SOFA) score ≥ 8 (OR 1.848 (1.100--3.105), *P* = 0.02) (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Risk factors in the final model for predicting airway failure, non-airway failure and extubation-failure. BMI, body mass index; SOFA, sequential organ failure assessment. In the final multivariate model constructed with the 1365 extubation procedures and all available data, the main predictors of airway failure were related to patient characteristics and conditions prior to extubation: female gender (OR 2.024 (1.187--3.450), *P* = 0.010), baseline pathology with coma as a reason for intubation (OR 4.979 (2.797--8.864), *P* \<£0.0001), acute respiratory failure as a reason for intubation (OR 3.395 (1.877--6.138), *P* \< 0.0001), length of ventilation \> 8 days (OR 1.956 (1.087--3.518), *P* = 0.025), copious secretions at the time of extubation (OR 4.066 (2.268--7.292), *P* \< 0.0001) and absence of strong cough before extubation (OR 1.876 (1.047--3.362), *P* = 0.035). The main predictors of non-airway failure were also related to patient characteristics and conditions prior to extubation: non-obese status (OR 2.153 (1.052--4.408), *P* = 0.036), baseline pathology with coma as a reason for intubation (OR 2.177 (1.301--3.642), *P* = 0.003), acute respiratory failure as a reason for intubation (OR 2.067 (1.217--3.510), *P* = 0.0072), absence of strong cough before extubation (OR 3.240 (1.786--5.879), *P* = 0.0001) and a SOFA score ≥ 8 (OR 1.848 (1.100--3.105), *P* = 0.02)

A center effect was assessed both as a fixed and random effect, but was not significant in the final model. After sensitivity analysis, including mixed airway and non-airway failures both in the airway failure and non-airway failure groups, all but one (length of ventilation \> 8 days, *P* = 0.066 for airway failure) of the same risk factors as in the main analysis were encountered. After additional sensitivity analysis, including only the first extubation for each patient, all but one (non-obese status, *P* = 0.054 for non-airway failure) of the same risk factors as in the main analysis were encountered. In a last sensitivity analysis, including excessive respiratory secretions in the non-airway failure group, the same risk factors but one (strong cough in the airway failure, *P* = 0.102) as in the main analysis were encountered. Additional details for sensitivity analysis are provided in Additional file [1](#MOESM1){ref-type="media"}.

Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"} present the main outcomes according to airway failure, non-airway failure and extubation success. Reintubation delays were longer in the case of non-airway failure when compared to airway failure (Table [3](#Tab3){ref-type="table"}). ICU and hospital mortality rates, hospital-acquired infection rate, and lengths of stay in the ICU and in hospital were higher in the case of airway failure and non-airway failure (Table [4](#Tab4){ref-type="table"}), as compared to extubation success. Overall, 268 patients (17.7%) were reintubated throughout the ICU stay, including 54 (3.6%) from day 2 to day 7, and 57 (3.8%) between day 7 and ICU discharge.Table 3Causes and time to reintubation according to airway failure and non-airway failure with corresponding crude odds ratios determined using multinomial logistic regressionCharacteristicAirway failure (*n* = 70)Non-airway failure (*n* = 78)*P* valueReintubation at 48 h70 (100)78 (100)-- Reintubation delay (hours)10.0 (4.0--24.0)24.0 (8.0--36.0)0.004 Cause of reintubation--  Hypoxia (SpO2 \< 90%)36 (51)47 (60)0.28  Tachypnoea \> 25/min30 (43)48 (62)0.02  Low arterial pressure (SAP \< 80 mmHg)2 (3)7 (9)0.17  Tachycardia \> 100/min17 (24)30 (38)0.06  Cardiac arrest0 (0)5 (6)0.06  Agitation10 (14)6 (8)0.20  Coma23 (33)12 (15)0.01 Difficult reintubation5 (7)2 (3)0.26 Stridor17 (24)4 (5)0.0009Data are summarized as number of extubation procedures/total number of extubation procedures (%) or median (interquartile range)*SpO2* peripheral oxygen saturation, *SAP* systolic arterial pressureTable 4Main outcomes according to airway failure, non-airway failure and extubation success with corresponding crude odds ratios determined using multinomial logistic regressionCharacteristicExtubation success (*n* = 1311)Airway failure (*n* = 65)Non-airway failure (*n* = 77)Airway vs non-airway failureOR95% CI*P* valueOR95% CI*P* value*P* value----------------Vasopressor use97 (7)16 (25)4.0872.240--7.454\< 0.000119 (25)4.1002.347--7.162\< 0.00010.99Dialysis use54 (4)6 (9)2.3670.979--5.7240.068 (10)2.7011.237--5.8970.010.82Hospital-acquired infections120 (9)22 (34)5.0782.939--8.775\< 0.000130 (39)6.3353.862--10.393\< 0.00010.53 Pneumonia63 (5)16 (25)6.4683.485--12.006\< 0.000126 (34)10.0995.910--17.258\< 0.00010.23 Catheter23 (2)3 (5)2.7130.794--9.2750.113 (4)2.2700.666--7.7340.191.00 Bloodstream63 (5)5 (8)1.6510.640--4.2550.3010 (13)2.9571.452--6.0200.0030.77 Urinary tract29 (2)5 (8)3.6841.377--9.8530.0095 (7)3.0701.154--8.1660.021.00Length of ICU stay6.0 (2.0--13.0)17.5 (11.0--30.0)1.0381.025--1.051\< 0.000116.5 (11.0--26.0)1.0251.012--1.0390.00020.32Length of hospital stay17.0 (9.0--31.0)28.5 (18.0--47.0)1.0111.005--1.0170.000526.0 (13.0--41.0)1.0091.003--1.0150.00210.28Patient alive at ICU discharge1237 (94)52 (80)0.2390.125--0.459\< 0.000160 (78)0.2110.117--0.380\< 0.00010.76Patient alive at hospital discharge1182 (90)48 (74)0.3080.172--0.552\< 0.000153 (69)0.2410.144--0.552\< 0.00010.51Data are summarized as number of patients/total number of patients (%) or median (interquartile range). All *P* values and OR result from a univariate multinomial logistic regression predicting the two modalities of extubation failure (airway failure vs non-airway failure) according to the characteristics*OR* odds ratio, *CI* confidence interval, *ICU* intensive care unit\*In the case of reintubation, several causes of reintubation could be provided for airway failure, non-airway failure or mixed airway and non-airway failures

Discussion {#Sec9}
==========

This study identified respective risk factors for airway failure versus non-airway failure among cases of extubation failure in a large multicenter, prospective cohort of extubated medical-surgical ICU patients. Extubation failure was a frequent event, occurring in 10.4% of cases, with half due to airway failure and half due to non-airway failure. Using multivariate multinomial logistic regression analysis, we identified specific risk factors for airway failure and non-airway failure, respectively.

Anticipating extubation failure is a challenging issue. As observed in the current study for both airway failure and non-airway failure, extubation failure is known to be associated with increased morbidity and mortality \[[@CR3], [@CR4]\]. Many studies \[[@CR26]\] attempted to identify risk factors for extubation failure in order to prevent it. Nevertheless, the incidence of extubation failure reported in the literature remains quite high, as in the current study, around 10% \[[@CR3], [@CR27]\]. Failure in predicting extubation success could be partly explained by the lack of differentiation between airway failure and non-airway failure. The aim of the study defined a priori was therefore to separate airway and non-airway failure, developing a new concept \[[@CR28]\], and not to create a score mixing all the extubation failures. Further studies will be needed to develop and validate scores predicting airway and non-airway failure. Airway failure, defined as an inability to breathe without a tracheal tube, is a different entity from non-aiway failure or weaning failure, defined as an inability to breathe without a ventilator that delivers ventilatory support \[[@CR10]\]. In order to attempt improvement in predicting extubation failure and associated morbimortality, we sought to separately identify risk factors for airway failure and non-airway failure by splitting extubation failure as a whole into airway failure and non-airway failure. Multinomial logistic regression is a classification method that generalizes logistic regression to multiclass problems (such as extubation failure), i.e. with more than two possible discrete outcomes (i.e. airway failure, non-airway failure, extubation success) \[[@CR24]\]. This study showed that certain risk factors were common to both airway failure and non-airway failure (intubation for coma, intubation for acute respiratory failure, absence of strong cough), three risk factors were specific to airway failure (female sex, length of ventilation \> 7 days, copious secretions) and two others specific to non-airway failure (non-obese status, SOFA score ≥ 8) (Fig. [2](#Fig2){ref-type="fig"}).

To our knowledge, this is the first time that an analysis of failure to be liberated from invasive mechanical ventilation, separating airway failure from non-airway failure, has been performed in a large ICU cohort, including 1514 extubation procedures and 157 extubation failures (Fig. [1](#Fig1){ref-type="fig"}). Optimal and individualized patient management prior to extubation may be more efficient in preventing extubation failure if the clinician thought separately in terms of airway failure (intensive physiotherapy in the case of low cough-expiratory flow \[[@CR29], [@CR30]\], steroids in patients at high risk of stridor \[[@CR20]\], sedation-analgesia optimization \[[@CR31], [@CR32]\], preparation of appropriate material if extubation is performed \[[@CR33], [@CR34]\]) versus non-airway failure (fluid restriction or diuretics \[[@CR35], [@CR36]\], preventive use of non-invasive ventilation (NIV) \[[@CR37]\], tracheostomy or delayed extubation in the case of diaphragm dysfunction \[[@CR18], [@CR38], [@CR39]\] and optimal treatment of pulmonary infection \[[@CR40]\]).

The risk factors found in the present study generally agreed with the risk factors for extubation failure identified in the existing literature \[[@CR3], [@CR4], [@CR41]--[@CR44]\]. The strongest predictors for planned extubation failure in a recent study of Thille et al. \[[@CR42]\] were also identified as risk factors for extubation failure in the present study: duration of mechanical ventilation longer than 1 week prior to extubation (length of intubation \> 8 days in the present study, a specific risk factor for airway failure), ineffective cough (a risk factor for airway failure and non-airway failure), and severe systolic left ventricular dysfunction (correlated with a SOFA score ≥ 8, a risk factor for non-airway failure). Female sex was also found as a risk factor for post-extubation stridor in previous studies, probably resulting from small airway size and a large endotracheal tube size in relation to laryngeal size \[[@CR45], [@CR46]\]. Obesity might be associated with a better prognosis in both acute respiratory distress syndrome \[[@CR47]\] and overall for ICU patients \[[@CR48]\]. The "obesity paradox" also seems present after extubation, and more accurately in non-airway failure following extubation. Baseline diseases (intubation for coma and/or acute respiratory failure) were both risk factors for airway failure and non-airway failure in the present study, and are consistent with the literature on extubation failure. The prevalence of extubation failure is higher in brain-injured patients, respectively 24% and 23% at 48 h in two recent multicenter studies \[[@CR44], [@CR49]\]. Additionally, Frutos-Vivar et al. \[[@CR43]\] have shown that pneumonia as the reason for initiating mechanical ventilation was an independent risk factor for extubation failure. As in the current study, copious secretions and agitation were identified as risk factors for extubation failure in previous studies \[[@CR3], [@CR42]\].

The study has certain limitations and strengths requiring discussion. First, correct classification into airway failure versus non-airway failure was challenging, while the Epstein definitions were used for classification \[[@CR10]\]. To limit the misclassification of each cause of extubation failure, two persons in each participating ICU assessed the main cause of extubation failure and in case of disagreement and/or difficulty in classification, two independent observers made the final classification. Moreover, two sensitivity analysis were performed, including either mixed airway and non-airway failures in both the airway failure and non-airway failure groups, or excess respiratory secretions in the non-airway failure group instead of the airway failure group, Both sensitivity analyses showed similar results than in the main analysis. Second, a weaning test was only performed in 77% of the cohort. Despite the primary interest of a well-conducted SBT, variation in SBT performance and documentation across and within sites has been previously described \[[@CR50]\]. Moreover, a weaning test may sometimes seem pointless when dealing with a short duration of mechanical ventilation, as all cases of extubation were included in the present study regardless of the duration of mechanical ventilation, which is also a strength of the study. It is worth noting that, for this reason, physiotherapy was used in half of the cases, because it is not systematically used in the participating units in case of reduced length of mechanical ventilation. Third, this pragmatic non-interventional observational study reflected French ICU practices in "real life". Some specific risk factors, such as cough strength determined using a peak flow system, rapid shallow breathing index, maximal inspiratory and expiratory pressures or airway occlusion pressure, were not assessed in practice, which is also a strength of this observational study, which sought to identify risk factors among those representing usual care. High-flow nasal cannula therapy was not used at this time in the participating centers. Fourth, we cannot exclude that the observed results in the final multivariate models could be the result of sampling variance \[[@CR51]\]. However, our results were consistent after several sensitivity analyses (see Additional file [1](#MOESM1){ref-type="media"}). Fifth, a few data were missing for the variables included in the multivariate analysis (*n* = 1368/1514, 9.8%). This small amount of missing data, not for the primary outcome, can be considered as missing completely at random (MCAR), which allowed complete case analysis \[[@CR52]\].

Conclusions {#Sec10}
===========

To conclude, this is the first large study to differentiate airway failure and non-airway failure among cases of ICU extubation failure. Specific risk factors have been identified, allowing to distinguish between risk of airway failure and non-airway failure. The two conditions will be managed differently, both for prevention and curative strategies. An individualized strategy separating airway failure from non-airway failure may help clinicians improve patient management before liberation from invasive mechanical ventilation.
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================

 {#Sec11}

Additional file 1Additional data are presented: data collection in the methods section, sensitivity analyses in the results section, additional **Figure S1** pointing out the definitions used in the study, and two supplemental **Tables S1** and **S2** providing supplemental patients and spontaneous breathing trials characteristics. (DOCX 107 kb)

CI

:   Confidence intervals

ICU

:   Intensive care unit

MCAR

:   Missing completely at random

OR

:   Odds ratio

SBT

:   Spontaneous breathing trial
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